Growth Hormone Peptides
Cross-source consensus on Growth Hormone Peptides from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Benefits
Highlighted claims
- CJC-1295 combined with Ipamorelin stimulates growth hormone release from the anterior pituitary via complementary GHRH and GHRP mechanisms. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- Tesamorelin is FDA-approved for reducing abdominal adiposity in HIV-associated lipodystrophy and can be used adjunctively after GLP-1 therapy. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- MK-677 (ibutamoren) is a ghrelin mimetic that stimulates growth hormone release and promotes muscle mass accumulation. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- The physiologic feedback loop of CJC-1295/Ipamorelin causes receptor downregulation with excess use, preventing runaway GH elevation and making it safer than exogenous anabolic hormones. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- AOD 9604 mimics the fat-reducing effects of growth hormone without affecting blood glucose levels. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation
- CJC-1295/Ipamorelin is associated with enhanced Delta sleep, the restorative deep sleep stage. — Peptide Therapy: A Clinical Guide to Applications, Evidence, and Implementation